. . . . . . . "[However, in mice treated with low-dose mercaptopurine (such as tolerated by TPMT-/- patients), the difference in 30-day leukemia-free survival by Tpmt genotype was profound: 5% (�9%) for Tpmt+/+ mice, 47% (�26%) for Tpmt+/- mice, and 85% (�14%) for Tpmt-/- mice (P=5�10), indicating a substantial impact of host Tpmt status on thiopurine effectiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:17:02+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .